Clinical trial
Vinorelbine and Oxaliplatin (Vinox) With or Without Trastuzumab (Herceptin®) in…
NCT00403988 · American University of Beirut Medical Center, Other · Terminated
Key facts
| NCT number | NCT00403988 |
|---|---|
| Title | Vinorelbine and Oxaliplatin (Vinox) With or Without Trastuzumab (Herceptin®) in Advanced Breast Carcinoma |
| Official title | A Clinical Phase II Study of Vinorelbine and Oxaliplatin (Vinox) With or Without Trastuzumab (Herceptin®) in Advanced Breast Carcinoma |
| Lead sponsor | American University of Beirut Medical Center, Other |
| Collaborators | Sanofi Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Neoplasms |
| Intervention type | Drug |
| Interventions | Oxaliplatin, vinorelbine |
| Enrollment | 40 |
| Start date | Jun 1, 2004 |
| Completion | Dec 1, 2007 |
| First posted | Nov 27, 2006 |
| Last update posted | Nov 4, 2008 |
| Countries | Lebanon |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: